Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 11/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17548770 | 0.87 | AHR (0.49) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL19636291 | 0.81 | AHR (0.49) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL16999821 | 0.81 | AHR (0.65) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL17548817 | 0.80 | AHR (0.47) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL29506383 | 0.78 | AHR (0.61) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL31850 | 0.78 | AHR (0.61) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL29470197 | 0.78 | AHR (0.61) | AHRMAPTMEN1KMT2ARAB9A | |
| SCHEMBL30340721 | 0.78 | GPR3 (0.50) | MAPTMEN1KMT2ARAB9AALDH1A1 | |
| SCHEMBL1294718 | 0.78 | GPR3 (0.50) | MAPTMEN1KMT2ARAB9AALDH1A1 | |
| SCHEMBL20966298 | 0.78 | AHR (0.52) | AHRMAPTMEN1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| WO-2016032150-A2 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2016-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | ORAI2, VDAC2, PIEZO1 | AHR 765/4885MAPT 954/4885MEN1 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.